Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China flag China · Delayed Price · Currency is CNY
4.770
0.00 (0.00%)
Jul 30, 2026, 3:04 PM CST

SHE:002370 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
101.5296.3134.24-11.88-132.69-228.28
Depreciation & Amortization
27.0627.0636.9338.7141.6143.78
Other Amortization
4.74.70.212.292.161.85
Loss (Gain) From Sale of Assets
0.060.060.01-0.4-0.04-4.96
Asset Writedown & Restructuring Costs
10.9610.960.167.6147.6662.63
Loss (Gain) From Sale of Investments
-151.07-151.07-55.45-3.8116.68-24.42
Provision & Write-off of Bad Debts
0.240.240.590.631.95-
Other Operating Activities
24.7243.7135.5647.4647.7748.04
Change in Accounts Receivable
59.3159.313.5474.93-152.7576.03
Change in Inventory
-49.44-49.4413.822.83-26.2-10.51
Change in Accounts Payable
-13.06-13.06-45.49-144.02168.5129.22
Operating Cash Flow
15.1228.924.3514.6512.04-3.84
Operating Cash Flow Growth
-46.45%18.66%66.21%21.68%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-6.62-5.05-9.92-7.46-21.1-15.78
Sale of Property, Plant & Equipment
0.010.01-0.430.15129.6
Cash Acquisitions
-50-----
Divestitures
144.78174.78----
Investment in Securities
20.851.180.94.99-1.92
Other Investing Activities
1.423.2316.022.035.1814.75
Investing Cash Flow
110.44174.157.01-0.01-15.76130.33

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
--305080-
Total Debt Issued
--305080-
Short-Term Debt Repaid
--277.23-50-50-140-84
Long-Term Debt Repaid
----0.34-1.08-1.42
Total Debt Repaid
-277.23-277.23-50-50.34-141.08-85.42
Net Debt Issued (Repaid)
-277.23-277.23-20-0.34-61.08-85.42
Common Dividends Paid
-37.12-37.37-11.9-16.5-13.88-13.34
Other Financing Activities
---0-0--109.55
Financing Cash Flow
-314.35-314.6-31.91-16.84-74.96-208.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-188.79-111.56-0.54-2.19-78.68-81.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
8.523.8414.447.19-9.06-19.62
Free Cash Flow Growth
-59.10%65.18%100.70%---
Free Cash Flow Margin
2.67%7.38%3.56%1.71%-2.43%-6.23%
Free Cash Flow Per Share
0.010.030.020.01-0.02-0.04
Levered Free Cash Flow
-47.66-13.66-1.2-63.12-37.03-79.36
Unlevered Free Cash Flow
-27.518.0317.92-33.46-4.33-43.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
17.5317.2122.7926.89.0826.89
Change in Working Capital
-3.06-3.06-27.89-65.95-13.0697.51